InChI=1S/C35H49N9O9/c1- 17(2) 12- 23- 32(50) 42- 25(14- 27(36) 46) 31(49) 39- 18(3) 30(48) 41- 24(13- 20- 15- 37- 22- 9- 6- 5- 8- 21(20) 22) 33(51) 43- 29(19(4) 45) 35(53) 44- 11- 7- 10- 26(44) 34(52) 38- 16- 28(47) 40- 23/h5- 6,8- 9,15,17- 19,23- 26,29,37,45H,7,10- 14,16H2,1- 4H3,(H2,36,46) (H,38,52) (H,39,49) (H,40,47) (H,41,48) (H,42,50) (H,43,51) /t18- ,19+,23- ,24- ,25- ,26- ,29- /m0/s1 |
BJDACJTXTXRXOB-YOGBPHHOSA-N |
[H] [C@@] 12CCCN1C(=O) [C@@] ([H] ) (NC(=O) [C@H] (Cc1c[nH] c3ccccc13) NC(=O) [C@H] (C) NC(=O) [C@H] (CC(N) =O) NC(=O) [C@H] (CC(C) C) NC(=O) CNC2=O) [C@@H] (C) O |
|
Annona montana
(NCBI:txid49857)
|
Found in
seed
(BTO:0001226).
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
View more via ChEBI Ontology
cyclo(L- alanyl- L- tryptophyl- L- threonyl- L- prolylglycyl- L- leucyl- L- asparaginyl)
|
2- [(6S,9R,12S,15S,18S,23aS)- 18- [(1R)- 1- hydroxyethyl]- 15- (1H- indol- 3- ylmethyl)- 12- methyl- 6- (2- methylpropyl)- 1,4,7,10,13,16,19- heptaoxodocosahydro- 1H- pyrrolo[1,2- a][1,4,7,10,13,16,19]heptaazacyclohenicosin- 9- yl]acetamide
|
ChEBI
|
18863997
|
Reaxys Registry Number
|
Reaxys
|
18687006
|
PubMed citation
|
Europe PMC
|
|